Value of 18F-FDG PET/CT radiomics combined with clinical features for predicting Ki-67 expression in colorectal cancer
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Objective To evaluate the value of 18F-FDG PET/CT radiomics combined with clinical features for the preoperative prediction of Ki-67 expression in colorectal cancer (CRC). Methods A total of 117 patients with pathologically confirmed CRC who underwent pretreatment 18F-FDG PET/CT between June 2016 and October 2024 were retrospectively included. Patients were classified into high- and low-expression groups using a 50% Ki-67 cutoff and were randomly divided into a training cohort and an internal validation cohort at a 7:3 ratio. Radiomic features were extracted from CT and PET images and reduced by standardization, univariate screening, correlation analysis, and least absolute shrinkage and selection operator (LASSO) regression. Logistic regression (LR), support vector machine (SVM), k-nearest neighbors (KNN), ExtraTrees, LightGBM, and multilayer perceptron (MLP) classifiers were compared. Independent clinical predictors were identified to construct a clinical model and a combined clinical-radiomics nomogram. Model performance was assessed using receiver operating characteristic (ROC) analysis, the DeLong test, and decision curve analysis (DCA). Results Six CT features, four PET features, and ten combined PET/CT features were retained. TNM stage, SUVmax, and SUVmean were independent predictors of high Ki-67 expression. The LightGBM-based PET/CT radiomics model achieved AUCs of 0.943 and 0.911 in the training and internal validation cohorts, respectively, with an accuracy of 0.861 in the validation cohort. The combined nomogram achieved AUCs of 0.951 and 0.913, with validation-cohort accuracy, sensitivity, specificity, and F1 score of 0.917, 0.920, 0.909, and 0.939, respectively. The AUC difference between the combined model and the PET/CT radiomics model was not statistically significant, whereas DCA showed a higher net benefit for the combined model within part of the clinically relevant threshold range. Conclusion Multimodal 18F-FDG PET/CT radiomics characterizes CRC from complementary morphologic and metabolic perspectives. Combining radiomics with TNM stage and conventional metabolic parameters may improve preoperative identification of high Ki-67 expression. External validation is required before clinical implementation.
Source: Research Square
Authors: ShuangronD Tian, yu zhang, Hu Wang
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7226010470
